CI_with has_Ingredient has_MoA has_PE may_prevent may_treat Dermatitis, Atopic [Disease/Finding] Drug Hypersensitivity [Disease/Finding] Graft vs Host Disease [Disease/Finding] Tacrolimus [Chemical/Ingredient] Cellular Growth Phase Arrest [PE] Decreased Cytokine Production [PE] Decreased T Lymphocyte Production [PE] Unknown Cellular or Molecular Interaction [MoA] T [Preparations] TACROLIMUS <VANDF_Record>50.416^3525^</VANDF_Record><VA_File>50.416</VA_File><VA_IEN>3525</VA_IEN> Tacrolimus N0000148372 4020868 <VANDF_Record>50.6^3228^</VANDF_Record><VA_File>50.6</VA_File><VA_IEN>3228</VA_IEN> Ingredient C20568 C0085149 42316 TACROLIMUS WM0HAQ4WNM Active